Candriam SCA’s NEVRO CORP. NVRO Stock Holding History

Candriam SCA’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,996	Closed	-$499K	–	883
2023 Q1	$499K	Sell	14,996 -6,282	-30%	-$221K	﹤0.01%	770
2022 Q4	$843K	Sell	21,278 -224	-1%	-$9.31K	0.01%	736
2022 Q3	$1M	Buy	+21,502	New	+$998K	0.01%	708

Other funds holding NVRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Candriam SCA's NVRO Position: Q2 2023 in Review

Candriam SCA sold out of NEVRO CORP. (NVRO) in Q2 2023, closing a stake of 14,996 shares — an estimated $499K sold.

Candriam SCA first reported a position in NVRO in Q3 2022 and held it in 3 quarters. The position peaked at $1M in Q3 2022. 155 funds tracked by Wall St. Rank hold NVRO as of Q2 2023.

Candriam SCA reported no remaining NEVRO CORP. position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 14,996 NEVRO CORP. shares in Q2 2023, an estimated $499K.
Candriam SCA first reported a position in NEVRO CORP. in Q3 2022 and held it in 3 quarters.
Candriam SCA's NEVRO CORP. position peaked at $1M in Q3 2022.
155 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.